IRIS Accounts Production v26.2.0.496 10233347 director 1.1.25 31.12.25 31.12.25 0 0 false true false false true false Ordinary 0.50000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102333472024-12-31102333472025-12-31102333472025-01-012025-12-31102333472023-12-31102333472024-01-012024-12-31102333472024-12-3110233347ns15:EnglandWales2025-01-012025-12-3110233347ns14:PoundSterling2025-01-012025-12-3110233347ns10:Director12025-01-012025-12-3110233347ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3110233347ns10:SmallEntities2025-01-012025-12-3110233347ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3110233347ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3110233347ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3110233347ns10:FullAccounts2025-01-012025-12-3110233347ns10:OrdinaryShareClass12025-01-012025-12-3110233347ns10:RegisteredOffice2025-01-012025-12-3110233347ns5:CurrentFinancialInstruments2025-12-3110233347ns5:CurrentFinancialInstruments2024-12-3110233347ns5:ShareCapital2025-12-3110233347ns5:ShareCapital2024-12-3110233347ns5:RetainedEarningsAccumulatedLosses2025-12-3110233347ns5:RetainedEarningsAccumulatedLosses2024-12-311023334712025-01-012025-12-3110233347ns5:ComputerEquipment2025-01-012025-12-3110233347ns5:ComputerEquipment2024-12-3110233347ns5:ComputerEquipment2025-12-3110233347ns5:ComputerEquipment2024-12-3110233347ns5:CostValuation2024-12-3110233347ns5:DisposalsRepaymentsInvestments2025-12-3110233347ns5:CostValuation2025-12-3110233347ns10:OrdinaryShareClass12025-12-3110233347ns5:RetainedEarningsAccumulatedLosses2024-12-3110233347ns5:RetainedEarningsAccumulatedLosses2025-01-012025-12-311023334712025-01-012025-12-31
REGISTERED NUMBER: 10233347 (England and Wales)







Unaudited Financial Statements

for the Year Ended 31st December 2025

for

Westbay Labs Ltd

Westbay Labs Ltd (Registered number: 10233347)






Contents of the Financial Statements
for the Year Ended 31st December 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Westbay Labs Ltd

Company Information
for the Year Ended 31st December 2025







DIRECTOR: Mr Paul McGrath





REGISTERED OFFICE: 40 Bayham Road
Bristol
City of Bristol
BS4 2DR





REGISTERED NUMBER: 10233347 (England and Wales)





ACCOUNTANTS: Dunkley's
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
United Kingdom
BS32 4JY

Westbay Labs Ltd (Registered number: 10233347)

Balance Sheet
31st December 2025

31.12.25 31.12.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 241 448
Investments 5 - 77,069
241 77,517

CURRENT ASSETS
Debtors 6 - 101
Cash at bank 46,207 2,319
46,207 2,420
CREDITORS
Amounts falling due within one year 7 8,174 29,042
NET CURRENT ASSETS/(LIABILITIES) 38,033 (26,622 )
TOTAL ASSETS LESS CURRENT LIABILITIES 38,274 50,895

PROVISIONS FOR LIABILITIES 46 85
NET ASSETS 38,228 50,810

CAPITAL AND RESERVES
Called up share capital 10 1 1
Retained earnings 11 38,227 50,809
SHAREHOLDERS' FUNDS 38,228 50,810

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11th September 2026 and were signed by:




Mr Paul McGrath - Director


Westbay Labs Ltd (Registered number: 10233347)

Notes to the Financial Statements
for the Year Ended 31st December 2025

1. STATUTORY INFORMATION

Westbay Labs Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in sterling (£), which is the functional currency of the company.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the Company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources.

The estimates and associated assumptions are based on historical experience and other factors considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of revision and future periods if the revision affects both current and future periods.

The following are the critical judgements and key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year:

Impairment of trade debtors - The Company makes an estimate of the recoverable value of trade and other debtors. When assessing impairment, management considers factors including the ageing profile of debtors and historical experience.

Useful economic lives of tangible fixed assets - The annual depreciation charge depends on the estimated useful lives of assets. The directors review these estimates regularly based on the current condition of the assets and expected future use.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - Straight line over 3 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Westbay Labs Ltd (Registered number: 10233347)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2025

2. ACCOUNTING POLICIES - continued

Going concern
The financial statements have been prepared on a going concern basis. The directors have considered the Company's financial position and are satisfied that it has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Financial instruments
The Company has elected to apply the provisions of Section 11 'Basic Financial Instruments'.
Financial instruments are recognised in the Company's balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets: Short-term debtors are measured at transaction price, less any impairment. Loans receivable are initially measured at transaction price (including transaction costs) and subsequently measured at amortised cost using the effective interest method, less any impairment.
Basic financial liabilities: Short-term creditors are measured at transaction price. Other financial liabilities, including bank loans and other loans, are initially measured at transaction price (including transaction costs) and subsequently measured at amortised cost using the effective interest method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1st January 2025 3,218
Disposals (599 )
At 31st December 2025 2,619
DEPRECIATION
At 1st January 2025 2,770
Charge for year 207
Eliminated on disposal (599 )
At 31st December 2025 2,378
NET BOOK VALUE
At 31st December 2025 241
At 31st December 2024 448

Westbay Labs Ltd (Registered number: 10233347)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2025

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1st January 2025 77,069
Disposals (77,069 )
At 31st December 2025 -
NET BOOK VALUE
At 31st December 2025 -
At 31st December 2024 77,069

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Other debtors - 101

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Other creditors - 1,200
Directors' current accounts 6,853 26,583
Accrued expenses 1,321 1,259
8,174 29,042

8. LEASING AGREEMENTS
The Company had no material commitments under non-cancellable operating leases at the balance sheet date.

9. SECURED DEBTS

The Company had no secured liabilities at the balance sheet date.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.25 31.12.24
value: £    £   
2 Ordinary £0.50 1 1

11. RESERVES
Retained
earnings
£   

At 1st January 2025 50,809
Deficit for the year (12,582 )
At 31st December 2025 38,227

Westbay Labs Ltd (Registered number: 10233347)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2025

12. CONTINGENT LIABILITIES

The Company had no contingent liabilities at the balance sheet date.

13. RELATED PARTY DISCLOSURES

At the balance sheet date, the Company owed £6,853 (2024: £26,583) to a director. The balance is unsecured, interest-free and repayable on demand.

14. POST BALANCE SHEET EVENTS

There have been no material events after the balance sheet date requiring disclosure in these financial statements.

15. CASH AND CASH EQUIVALENTS

Cash comprises cash in hand and demand deposits. Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and are subject to an insignificant risk of changes in value.

Cash and cash equivalents consist solely of balances held in the Company's bank current account. The Company does not hold any short-term investments and does not operate an overdraft facility.